14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
IREN vs NMR: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, Nomura Holdings, Inc (NMR) is the stronger overall head-to-head candidate over IREN Limited (IREN) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). IREN carries a Unified Composite Score of 42.9/100 (HOLD) at $15.81 (65.4x Forward P/E, -72.9% operating margin), whereas NMR carries 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin).
Technical & Structure Timing Caution: IREN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 29.5); meanwhile NMR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IREN vs NMR. Trailing 12-month operating profitability (IREN -72.9% vs NMR 25.1%) and valuation multiples (IREN 65.4x vs NMR 12.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Capital Markets value chain with $7.7B market capitalization and -72.9% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
NMR Moat ProfileScale & Operating Efficiency Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $28.3B market capitalization and 25.1% operating margin.
OpEx & R&D Reinvestment52.3% of Rev ($7.77B)
90D Engineering Disclosures0 Published
Investor FAQ IREN vs NMR Key Questions & Quantitative Answers
As of Nov 17, 2026, Nomura Holdings, Inc (NMR) is the stronger overall head-to-head candidate over IREN Limited (IREN) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). IREN carries a Unified Composite Score of 42.9/100 (HOLD) at $15.81 (65.4x Forward P/E, -72.9% operating margin), whereas NMR carries 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin). Technical & Structure Timing Caution: IREN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 29.5); meanwhile NMR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
NMR leads the Growth & Scale pillar: IREN posts -5.0% YoY revenue growth and +42.9% YoY earnings growth on $695M TTM revenue (73.4% gross margin, -72.9% operating margin), compared with NMR at +17.9% YoY revenue growth and +13.6% YoY earnings growth on $14.9B TTM revenue (77.4% gross margin, 25.1% operating margin). On trailing 12-month operating scale, IREN generates $695M in USD-normalized revenue versus $14.9B for NMR. In operating R&D and SG&A reinvestment, IREN deploys N/A (0 90-day corporate R&D disclosures) versus 52.3% of Rev ($7.77B) (0 disclosures) for NMR.
NMR screens cheaper on headline valuation multiples. IREN trades at 65.4x Forward P/E, 65.4x Trailing P/E, 4.05x PEG, and 20.7x EV/Revenue (unreported FCF margin), whereas NMR trades at 12.7x Forward P/E, 11.2x Trailing P/E, 0.81x PEG, and 1.9x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IREN (-33.8% ROE) versus NMR (11.5% ROE) capital efficiency.
In options market volatility and institutional positioning, IREN carries 129.7% implied volatility (32nd %ile, Balanced (25th–60th %ile)), a 2.69x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (3.88β · 136% Vol realized risk). By comparison, NMR carries 30.7% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.03β · 29% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.